以原发意图进行的细胞减灭术与在新辅助化疗后进行的细胞减灭术对晚期上皮性卵巢癌患者预后的影响:FRANCOGYN 组的一项多中心倾向性评分匹配研究
该多中心倾向性评分匹配队列研究比较了晚期上皮性卵巢癌患者初次细胞减灭术(pCRS)与中间型细胞减灭术(iCRS)的生存与并发症,匹配后167对患者总生存无差异(HR=0.8,p=0.32),但pCRS组胃肠道切除、造口、术后并发症及住院时间显著更高。
要点
- 匹配后pCRS与iCRS总生存无差异(HR=0.8,p=0.32)。
- 两组无复发生存中位均为26个月,无肉眼残留率pCRS 85% vs iCRS 81.4%(p=0.76)。
- pCRS组胃肠道切除、造口、术后并发症及住院时间显著更高。
核心结论
- 倾向性评分匹配后两组生存无差异,但iCRS组术后并发症更低。
研究设计与样本
- 多中心倾向性评分匹配队列研究,使用FRANCOGYN队列数据,纳入FIGO III或IV期上皮性卵巢癌伴腹膜癌播散并接受细胞减灭术的患者,共513例,其中334例可匹配形成167对。
主要发现
- 总生存无差异(HR=0.8,p=0.32)。
- 无复发生存两组中位均为26个月。
- 无肉眼残留率pCRS 85% vs iCRS 81.4%(p=0.76)。
- pCRS组胃肠道切除、造口、术后并发症及住院时间显著高于iCRS组。
关键数值与推荐
- 无肉眼残留率pCRS 85% vs iCRS 81.4%(p=0.76)。
- 总生存HR=0.8,p=0.32。
- 无复发生存两组中位均为26个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare survival and morbidity rates between primary cytoreductive surgery (pCRS) and interval cytoreductive surgery (iCRS) for epithelial ovarian cancer (EOC), using a propensity score. DESIGN: We conducted a propensity score-matched cohort study, using data from the FRANCOGYN cohort. SETTING: Retrospective, multicentre study of data from patients followed in 15 French department specialized in the treatment of ovarian cancer. SAMPLE: Patients included were those with International Federation of Gynaecology and Obstetrics (FIGO) stage III or IV EOC, with peritoneal carcinomatosis, having undergone CRS. METHODS: The propensity score was designed using pre-therapeutic variables associated with both treatment allocation and overall survival (OS). MAIN OUTCOME MEASURES: The primary outcome was OS. Secondary outcomes included recurrence-free survival (RFS), quality of CRS and other variables related to surgical morbidity. RESULTS: A total of 513 patients were included. Among these, 334 could be matched, forming 167 pairs. No difference in OS was found (hazard ratio, HR = 0.8, p = 0.32). There was also no difference in RFS (median = 26 months in both groups) nor in the rate of CRS leaving no macroscopic residual disease (pCRS 85%, iCRS 81.4%, p = 0.76). The rates of gastrointestinal tract resections, stoma, postoperative complications and hospital stay were significantly higher in the pCRS group. CONCLUSIONS: Analysis of groups of patients made comparable by propensity score matching showed no difference in survival, but lower postoperative morbidity in patients treated with iCRS.
引用
- Wohrer H, Koual M, Bentivegna E, et al. Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score-matched study from the FRANCOGYN group. BJOG. 2023. PMID: 37165717. doi:10.1111/1471-0528.17524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。